These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 15456505)
1. Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven) after allogenic bone marrow transplantation. Karimi M; Zakerinia M; Khojasteh HN; Ramzi M; Ahmad E J Thromb Haemost; 2004 Oct; 2(10):1853-5. PubMed ID: 15456505 [No Abstract] [Full Text] [Related]
2. Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy. Ashrani AA; Gabriel DA; Gajewski JL; Jacobs DR; Weisdorf DJ; Key NS Bone Marrow Transplant; 2006 Dec; 38(12):825-8. PubMed ID: 17133240 [No Abstract] [Full Text] [Related]
3. Off-label use of recombinant factor VIIa in patients following bone marrow transplantation. Blatt J; Gold SH; Wiley JM; Monahan PE; Cooper HC; Harvey D Bone Marrow Transplant; 2001 Aug; 28(4):405-7. PubMed ID: 11571515 [TBL] [Abstract][Full Text] [Related]
4. Recombinant factor VIIa to treat late radiation-induced hemorrhagic cystitis: a case report. Geisler JP; Linnemeier GC; Manahan KJ J Reprod Med; 2008 May; 53(5):360-2. PubMed ID: 18567283 [TBL] [Abstract][Full Text] [Related]
5. Hemorrhagic cystitis complicating bone marrow transplantation. Letendre L; Hoagland HC; Gertz MA Mayo Clin Proc; 1992 Feb; 67(2):128-30. PubMed ID: 1545575 [TBL] [Abstract][Full Text] [Related]
6. [The prevention of hemorrhagic cystitis during the performance of bone marrow and peripheral blood stem cell transplantation in the hematologic cancer clinic]. Uss AL; Milanovich NF; Snegir' VM; Zmachinskiĭ VA; Skriagin AE Ter Arkh; 1996; 68(10):49-52. PubMed ID: 9026944 [TBL] [Abstract][Full Text] [Related]
7. Late onset hemorrhagic cystitis after allogeneic bone marrow transplantation. Shieh CC; Chen BW; Lin KH Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):508-11. PubMed ID: 2551995 [TBL] [Abstract][Full Text] [Related]
8. Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa. Hicks K; Peng D; Gajewski JL Bone Marrow Transplant; 2002 Dec; 30(12):975-8. PubMed ID: 12476294 [TBL] [Abstract][Full Text] [Related]
9. Recombinant FVIIa in the treatment of bleeding in acquired hemophilia. Guerin V; Chossat I; Dutronc H; Dubreuil M; Valentin F Am J Hematol; 2002 Aug; 70(4):333. PubMed ID: 12210820 [No Abstract] [Full Text] [Related]
10. Recombinant activated factor VII (NovoSeven) stops severe intra-abdominal bleeding after liver needle biopsy without surgery. Sendensky A; Gutzwiller JP; Schneider-Frost J; Wuillemin WA; Graeni R; Beglinger C Blood Coagul Fibrinolysis; 2004 Oct; 15(8):701-2. PubMed ID: 15613927 [No Abstract] [Full Text] [Related]
12. Successful application of epidermal growth factor for treatment of hemorrhagic cystitis after bone marrow transplantation. Dorticós E; Pavón V; Jaime JC; Reboredo M; López Saura P; Berlanga J; Hernández P Bone Marrow Transplant; 2003 Apr; 31(7):615-6. PubMed ID: 12692631 [No Abstract] [Full Text] [Related]
13. Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. Fanourgiakis P; Georgala A; Vekemans M; Triffet A; De Bruyn JM; Duchateau V; Martiat P; De Clercq E; Snoeck R; Wollants E; Rector A; Van Ranst M; Aoun M Clin Infect Dis; 2005 Jan; 40(1):199-201. PubMed ID: 15614713 [TBL] [Abstract][Full Text] [Related]
14. Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplant. Vela-Ojeda J; Tripp-Villanueva F; Sanchez-Cortés E; Ayala-Sanchez M; García-Ruiz Esparza MA; Rosas-Cabral A; Gonzalez-Llaven J Bone Marrow Transplant; 1999 Dec; 24(12):1307-10. PubMed ID: 10627639 [TBL] [Abstract][Full Text] [Related]
15. Recombinant activated factor VII to control life-threatening haemorrhagic radiation cystitis. Connolly SS; D'Arcy FT; Corcoran MO Ir J Med Sci; 2010 Sep; 179(3):431-3. PubMed ID: 19352582 [TBL] [Abstract][Full Text] [Related]
16. The use of recombinant factor VIIa in a patient with essential thrombocythaemia with uncontrolled surgical bleeding. Cervera JS; Mena-Durán AV; Piqueras CS Thromb Haemost; 2005 Feb; 93(2):383-4. PubMed ID: 15711760 [No Abstract] [Full Text] [Related]
17. Is recombinant FVIIa the magic bullet in the treatment of major bleeding? Spahn DR; Tucci MA; Makris M Br J Anaesth; 2005 May; 94(5):553-5. PubMed ID: 15814804 [No Abstract] [Full Text] [Related]
18. Successful use of recombinant factor VIIa in pelvic fracture haemorrhage. Dhruva KK; Joel VD; Antony S; Vinodan K J Indian Med Assoc; 2006 Jan; 104(1):42, 44. PubMed ID: 16850866 [TBL] [Abstract][Full Text] [Related]
19. [Administration of activated recombinant factor VII (novo seven) for the control of massive bleeding in gynecology]. Tanchev S; Pandurski F; Georgiev A; Gesheva Iu; Platikanov V; Dinov P Akush Ginekol (Sofiia); 2004; 43 Suppl 2():32-5. PubMed ID: 15518274 [TBL] [Abstract][Full Text] [Related]
20. Successful use of recombinant activated factor VII in controlling upper gastrointestinal bleeding in a patient with relapsed acute myeloid leukemia. Hoffman R; Eliakim R; Zuckerman T; Rowe JM; Brenner B J Thromb Haemost; 2003 Mar; 1(3):606-8. PubMed ID: 12871480 [No Abstract] [Full Text] [Related] [Next] [New Search]